PERISCOPE CAPITAL INC. - BIOTECH ACQUISITION COMPANY ownership

BIOTECH ACQUISITION COMPANY's ticker is BIOTW and the CUSIP is G1125A116. A total of 1 filers reported holding BIOTECH ACQUISITION COMPANY in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
PERISCOPE CAPITAL INC. ownership history of BIOTECH ACQUISITION COMPANY
ValueSharesWeighting
Q4 2022$6,390
+6.5%
100,0000.0%0.00%
Q3 2022$6,000
-85.0%
100,000
-39.5%
0.00%
-100.0%
Q1 2022$40,000
-64.3%
165,200
-2.8%
0.00%
-66.7%
Q4 2021$112,000
-31.7%
170,000
-31.5%
0.00%
-40.0%
Q3 2021$164,000
-23.0%
248,3000.0%0.01%
-28.6%
Q2 2021$213,000248,3000.01%
Other shareholders
BIOTECH ACQUISITION COMPANY shareholders Q1 2023
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 202,950$2,049,7750.06%
RAMIUS ADVISORS LLC 569,526$36,3920.04%
Telemetry Investments, L.L.C. 153,694$100.02%
BOOTHBAY FUND MANAGEMENT, LLC 60,493$610,9730.01%
MARSHALL WACE, LLP 575,000$5,807,5010.01%
Corbin Capital Partners, L.P. 464,062$29,6540.01%
Q Global Advisors, LLC 300,000$190.01%
Segantii Capital Management Ltd 25,000$252,0000.01%
LMR Partners LLP 50,000$504,9950.01%
HGC Investment Management Inc. 2,429,166$1510.01%
View complete list of BIOTECH ACQUISITION COMPANY shareholders